194 related articles for article (PubMed ID: 29070113)
1. [Retrospective Analysis of Clinical Features and Prognosis of 84 Patients with Extranodal NK/T Cell Lymphoma in One Center].
Yang QS; Zhao SH; Jiang Y; Jiang TY; Yuan SZ; Su H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1390-1396. PubMed ID: 29070113
[TBL] [Abstract][Full Text] [Related]
2. [Analysis on Clinical Characteristics and Prognosis of 47 Patients with Extranodal NK/T Cell Lymphoma].
Li QH; Yang P; Wang JJ; Dong F; Tian L; Wan W; Ke XY; Jing HM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Feb; 29(1):86-90. PubMed ID: 33554802
[TBL] [Abstract][Full Text] [Related]
3. [Extranodal NK/T-cell lymphoma, nasal type: a clinical analysis].
Chen F; Shen CX; Wang HG; Li GX; Wang XQ; Wen Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Mar; 31(5):327-333. PubMed ID: 29871255
[No Abstract] [Full Text] [Related]
4. CD56-negative extranodal NK/T cell lymphoma should be regarded as a distinct subtype with poor prognosis.
Wang L; Wang Z; Xia ZJ; Lu Y; Huang HQ; Zhang YJ
Tumour Biol; 2015 Sep; 36(10):7717-23. PubMed ID: 25935537
[TBL] [Abstract][Full Text] [Related]
5. Primary site and regional lymph node involvement are independent prognostic factors for early-stage extranodal nasal-type natural killer/T cell lymphoma.
Niu SQ; Yang Y; Li YY; Wen G; Wang L; Li ZM; Wang HY; Zhang LL; Xia YF; Zhang YJ
Chin J Cancer; 2016 Apr; 35():34. PubMed ID: 27044275
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
Yhim HY; Kim JS; Mun YC; Moon JH; Chae YS; Park Y; Jo JC; Kim SJ; Yoon DH; Cheong JW; Kwak JY; Lee JJ; Kim WS; Suh C; Yang DH;
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1597-604. PubMed ID: 25963920
[TBL] [Abstract][Full Text] [Related]
7. [Expression of CD7 and its correlation with prognosis in patients with NK/T-cell lymphoma].
Fu XR; Wan WJ; Sun ZC; Zhang XD; Nan FF; Ge JR; Xia YQ; Zhang MZ
Zhonghua Xue Ye Xue Za Zhi; 2020 Nov; 41(11):921-926. PubMed ID: 33333695
[No Abstract] [Full Text] [Related]
8. A clinical study of 115 patients with extranodal natural killer/T-cell lymphoma, nasal type.
Wu X; Li P; Zhao J; Yang X; Wang F; Yang YQ; Fang F; Xu Y; Zhang H; Wang WY; Yi C
Clin Oncol (R Coll Radiol); 2008 Oct; 20(8):619-25. PubMed ID: 18790372
[TBL] [Abstract][Full Text] [Related]
9. [Clinical Treatment and Prognosis of 61 Patients with Extranodal NK/T Cell Lymphoma].
Liu Y; Huang CL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):512-517. PubMed ID: 32319388
[TBL] [Abstract][Full Text] [Related]
10. Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study.
Xu Y; Wang J; Zhang W; Liu J; Cao X; He A; Chen Y; Gu L; Lei B; Zhang P; Ma X
Med Sci Monit; 2016 Nov; 22():4297-4311. PubMed ID: 27843135
[TBL] [Abstract][Full Text] [Related]
11. The role of Skp2 in extranodal NK/T-cell lymphoma.
Guo HQ; Pu XX; Guo CC; Rao HL; Li HR; Lin TY
Chin J Cancer; 2010 May; 29(5):567-71. PubMed ID: 20426910
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics and prognostic analysis of advanced-stage extranodal NK/T cell lymphoma].
Wei C; Zhang Y; Wang W; Zhang L; Zhang W; Zhou DB
Zhonghua Xue Ye Xue Za Zhi; 2020 Jun; 41(6):462-468. PubMed ID: 32654458
[No Abstract] [Full Text] [Related]
13. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
[TBL] [Abstract][Full Text] [Related]
14. [Clinical analyses of 24 patients with primary pulmonary NK/T-cell lymphoma].
Qiu YJ; Zhang MZ
Zhonghua Xue Ye Xue Za Zhi; 2020 Jan; 41(1):40-46. PubMed ID: 32023753
[No Abstract] [Full Text] [Related]
15. [Long-term effect of risk-adaptive therapy for early stage extranodal NK/T cell lymphoma].
Wu T; Liu QL; Hu YF; Zhang J; Chen MX; Chen XX; Huang YH; Lu B
Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):859-864. PubMed ID: 31770855
[No Abstract] [Full Text] [Related]
16. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
17. [Change of Plasma Interleukin-17 Level in Patients with Extranodal NK/T-Cell Lymphoma and Its Clinical Significance].
Shang CX; Ma JC; Nan Z; Li Y; He WC; Pan XY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):796-801. PubMed ID: 28641638
[TBL] [Abstract][Full Text] [Related]
18. [Clinical differences between primary nasopharyngeal NK/T-cell lymphoma and primary nasal cavity NK/T-cell lymphoma with nasopharynx extension].
Liu WX; Liu YP; Jin J; Wang SL; Fang H; Ren H; Song YW; Chen B; Lu NN; Li N; Tang Y; Qi SN; Tang Y; Wang WH; Li YX
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):56-62. PubMed ID: 30678418
[No Abstract] [Full Text] [Related]
19. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
[TBL] [Abstract][Full Text] [Related]
20. [Influence of Pre-treatment Lymphocyte/Monocyte Ratio and Neutrophil/Lymphocyte Ratio on the Prognosis of Patients with Extranodal NK/T-Cell Lymphoma].
Deng XY; Wang YY; Dang QQ; Liang TS; Zheng YJ; Yang DK
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):707-713. PubMed ID: 37356930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
